Here are relevant reports on : bone-growth-stimulators-market
-
Bone Growth Stimulator Market by Product (Device (External Bone Growth Stimulators), Platelet-Rich Plasma), Application (Spinal Fusion Surgeries, Oral & Maxillofacial Surgeries), End User (Hospital, Ambulatory Surgical Centers) & Region - Global Forecast to 2027
The global bone growth stimulator market in terms of revenue was estimated to be worth $1.4 billion in 2022 and is poised to reach $1.8 billion by 2027, growing at a CAGR of 5.9% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: October 2022
- Price: $ 4950
- TOC Available:
-
Bone Cement & Glue Market by Bone Cement (PMMA, Calcium Phosphate), Bone Glue (Natural, Synthetic), Loading (Antibiotic Loaded), Application (Arthroplasty, Kyphoplasty, Vertebroplasty), End User (Hospitals, ASCS, Clinics) & Region - Global Forecast to 2028
The global bone cement & glue market, valued at US$1,549 million in 2022, stood at US$1,644 million in 2023 and is projected to advance at a resilient CAGR of 6.5% from 2023 to 2028, culminating in a forecasted valuation of US$2,248 million by the end of the period. The growth of this market is majorly driven by Growing number of road traffic accidents and rising number of surgical procedures However, extensive clinical data requirements for launching new bone cements may restrain the growth of this market.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Biopsy Devices Market by Product (Core needle biopsy (Automatic, Disposable), Technology (Ultrasound,stereotactic), Application (Oncology, Gastroenterology, Bone & Bone marrow biopsy), End User (Diagnostic imaging centres) - Global Forecast to 2030
The global biopsy devices market, valued at US$6.86B in 2023, is forecasted to grow at a 7.2% CAGR, reaching US$7.27B by 2024 and US$11.01B by 2030. The rising prevalence of cancer. Additionally the increasing preference for minimally invasive surgeries. Moreover, the improved reimbursement policies is likely to promote the growth of biopsy device market.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Dental Bone Graft Substitutes Market by Type (Xenograft, Allograft, Synthetic Bone Grafts, Alloplast), Application (Sinus Lift, Ridge Augmentation, Socket Preservation), Product (BioOss, Osteograf, Grafton), End User, Region - Global Forecast to 2031
The global dental bone graft substitutes market, valued at USD 1.30 billion in 2025, stood at USD 1.40 billion in 2026 and is projected to advance at a resilient CAGR of 6.5% from 2026 to 2031, culminating in a forecasted valuation of USD 2.04 billion by the end of the period. This market has been expanding rapidly due to rising oral diseases, including tooth loss, edema, and periodontal disease, particularly among the aging population. As a result, there is a growing demand for implant surgeries, which require bone enhancement procedures before the actual implant can be placed.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Europe Dental Bone Graft Substitutes Market by Type (Xenograft, Allograft, Synthetic Bone Grafts, Alloplast), Application (Sinus Lift, Ridge Augmentation, Socket Preservation), Product (BioOss, Osteograf, Grafton), End User, Country - Forecast to 2031
The Europe Dental Bone Graft Substitutes market, valued at USD 411.1 million in 2025, stood at USD 441.3 million in 2026 and is projected to advance at a resilient CAGR of 6.4% from 2026 to 2031, culminating in a forecasted valuation of USD 641.5 million by the end of the period. The main factors driving this rise are the increased use of advanced regenerative materials in implantology and periodontal procedures.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Spinal Implants Market by Product (Devices (Thoracic, Cervical, Interbody Fusion, Spinal Non-Fusion), Biologics, Stimulators), Application (VCF, Spinal Decompression, Fusion, Non-Fusion), Surgery (Open, MIS), Region & Customer Unmet Need Forecast to 2028
The global spinal implants market, valued at US$10.7 billion in 2022, stood at US$11.2 billion in 2023 and is projected to advance at a resilient CAGR of 5.0% from 2023 to 2028, culminating in a forecasted valuation of US$14.3 billion by the end of the period. Increasing incidence of spinal disorder and research on spinal implants by key companies have resulted in the development are the major factors driving market growth.
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
Pulmonary Arterial Hypertension Market by Drug Class (SGC Stimulators, Endothelin Receptor Antagonists, Type (Innovative, Generics) – Global Forecast to 2027
The global pulmonary arterial hypertension market is projected to reach USD 9 billion by 2027 from USD 7 billion in 2022, at a CAGR of 5% during the forecast period
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Bone Cement & Accessories-Alternatives Market - 2019 By Types, Application & Geography
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Dental Biomaterials Market by Type (Metallic (Titanium, Stainless Steel, Chromium Alloy, Amalgam, Gold), PFM, Ceramic, Bone Graft, Polymer Biomaterials), Application (Implantology, Prosthetic, Orthodontic), End User & Region - Global Forecasts to 2023
The dental biomaterials market is projected to reach USD 9.6 billion by 2023, at a CAGR of 7.4%. The growing prevalence of dental disorders, rising geriatric population, and the growing dental tourism in emerging countries are the major factors driving the growth of this market. On the other hand, the presence of stringent regulatory and clinical processes is one of the major factors restraining market growth. The prominent players in the dental biomaterials market include Institut Straumann AG (Switzerland), Geistlich Pharma AG (Switzerland), Zimmer Biomet Holdings, Inc. (US), Danaher Corporation (US), Dentsply Sirona, Inc. (US), 3M Company (US), Royal DSM (Netherlands), Carpenter Technology Corporation (US), Kuraray Co., Ltd (Japan), Medtronic Plc. (Ireland), Henry Schein, Inc. (US), Mitsui Chemicals ,Inc. (Japan), Victrex Plc (UK), Ivoclar Vivadent AG (Principality of Liechtenstein), GC Corporation (Japan), Keystone Dental, Inc. (US), Datum Dental Ltd (Israel), BEGO Medical GmbH (Germany), and Cam Bioceramics B.V (Netherland).
- Published: January 2019
- Price: $ 4950
- TOC Available:
-
Hearing Aids Market by Product (Devices (RITE, BTE, Canal, ITE), Implants (Cochlear, Bone-anchored)), Type of Hearing Loss (Sensorineural, Conductive), Patient (Adults, Pediatrics), Technology (Digital, Analog), Channel & Region - Global Forecast to 2030
The global hearing aids market, valued at US$9.74 billion in 2024, stood at US$10.35 billion in 2025 and is projected to advance at a resilient CAGR of 6.8% from 2025 to 2030, culminating in a forecasted valuation of US$14.42 billion by the end of the period. Market growth in the Asia Pacific can be attributed to the rising elderly population and growing demand for ENT services. Increasing healthcare investments and growing medical tourism also contribute to regional market expansion.
- Published: July 2025
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
